Update on Treatment of Infantile Hemangiomas: What’s New in the Last Five Years?

Update on Treatment of Infantile Hemangiomas: What’s New in the Last Five Years?

Among benign vascular tumors of infancy, hemangiomas are the commonest, affecting approximately 5–10% of one-year-old children. They are derived from a benign proliferation of vascular endothelial cells (VECs) in the mesoderm and may arise anywhere on the body around 1–2 weeks after birth. Infantile...

Full description

Bibliographic Details
Main Authors: Laura Macca, Domenica Altavilla, Luca Di Bartolomeo, Natasha Irrera, Francesco Borgia, Federica Li Pomi, Federico Vaccaro, Violetta Squadrito, Francesco Squadrito, Mario Vaccaro
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Pharmacology
Subjects:
infantile hemangioma
steroids
propranolol
timolol
carteolol
itraconazole
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.879602/full

Similar Items

Similar Items